Back to homepage

Dermatology

Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patients

Authors: Tiago Torres, Margarida Gonçalo, Maria João Paiva Lopes, Cristina Claro, Leonor Ramos, Manuela Selores, Pedro Mendes Bastos, Joana Rocha, Rodrigo Carvalho, Alberto Mota, Paulo Filipe on Behalf of the Atopic Dermatitis Group of the Portuguese Society of Dermatology and Venereology

This article presents recommendations developed by the Atopic Dermatitis Group of the Portuguese Society of Dermatology and Venereology addressing several clinical questions that arise in the management and care of moderate-tosevere atopic dermatitis with biologic agents and Janus kinase inhibitors based on the available evidence.

More▸

Dermatology: how to manage acne vulgaris

Authors: Alexander KC Leung, Benjamin Barankin, Joseph M Lam, Kin Fon Leong, Kam Lun Hon

This article aims to provide a narrative updated review on the management of acne vulgaris.

More▸

Bilastine 10 and 20 mg in paediatric and adult patients: an updated practical approach to treatment decisions

Authors: Amalia Leceta, Aintzane García, Ander Sologuren, Cristina Campo

Keywords: allergic rhinoconjunctivitis, antihistamines, bilastine, drug information, drug interactions, medical information services, paediatrics, safety, urticaria. Citation: Leceta A, García A, Sologuren A, Campo C. Bilastine 10 and 20 mg in paediatric and adult patients: an updated practical approach to treatment

More▸

Treatment beyond progression and locoregional approaches in selected patients with BRAF-mutated metastatic melanoma

Authors: Francesco Serra, Carlotta Faverio, Angioletta Lasagna, Stefania Barruscotti, Tommaso Dominioni, Marco Benazzo, Paolo Pedrazzoli, Silvia Chiellino

The aim of this review is to investigate the role of treatment beyond progression and locoregional approaches in BRAF-mutated metastatic melanoma and provide oncologists dealing with this malignancy a useful road map on when and why to choose this strategy.

More▸

Erratum: Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting

Authors: Martina Burlando, Riccardo Castelli, Emanuele Cozzani, Aurora Parodi

Burlando M, Castelli R, Cozzani E, Parodi A. Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting. Drugs in Context 2021; 10: 2021-2-6. DOI: 10.7573/dic.2021-2-6

More▸